Possible pathological processes associated with impaired pulmonary function in T2DM may include non-enzymatic glycosylation of lung elastin structures, which could stiff the lung [40] and cause a restrictive impact on ventilation; and diabetes-induced microvascular complications, which could impair the diffusion [37, 41] and diminish gas exchange. Here, ELN is linked to type 2 diabetes mellitus.